Two new Pfizer-coauthored studies validate Novoheart's pioneering human bioengineered heart tissues and chambers for improving drug development TSX Venture Exchange:NVH.V

Press/Media

Period9 Sep 2019

Media coverage

1

Media coverage

  • TitleTwo new Pfizer-coauthored studies validate Novoheart's pioneering human bioengineered heart tissues and chambers for improving drug development TSX Venture Exchange:NVH.V
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    Country/TerritoryJordan
    Date9/09/19
    PersonsKevin Costa